Silverberg Bernstein Capital Management LLC raised its position in Pharming Group (NASDAQ:PHAR – Free Report) by 16.8% during the fourth quarter, HoldingsChannel reports. The firm owned 47,997 shares of the company’s stock after buying an additional 6,887 shares during the quarter. Silverberg Bernstein Capital Management LLC’s holdings in Pharming Group were worth $483,000 as of its most recent SEC filing.
Pharming Group Stock Performance
Shares of PHAR stock opened at $9.93 on Wednesday. Pharming Group has a 52-week low of $6.65 and a 52-week high of $13.20. The stock’s 50-day moving average price is $8.76 and its 200 day moving average price is $8.36. The company has a quick ratio of 2.76, a current ratio of 3.53 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $673.60 million, a PE ratio of -38.19 and a beta of -0.08.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on PHAR shares. Oppenheimer cut their target price on Pharming Group from $31.00 to $30.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. HC Wainwright reissued a “buy” rating and issued a $37.00 price target on shares of Pharming Group in a research report on Tuesday, December 17th. Finally, Jefferies Financial Group initiated coverage on Pharming Group in a report on Monday, December 9th. They set a “buy” rating and a $14.00 price objective on the stock.
Pharming Group Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Read More
- Five stocks we like better than Pharming Group
- Industrial Products Stocks Investing
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
- What Are the FAANG Stocks and Are They Good Investments?
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Can Integrated Healthcare Stocks Succeed in Public Markets?
Want to see what other hedge funds are holding PHAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pharming Group (NASDAQ:PHAR – Free Report).
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
